<?xml version="1.0" encoding="UTF-8"?>
<table id="PMC7090514/table_1" xmlns="http://www.w3.org/1999/xhtml">
 <caption>
  <label>Table 1</label>
  <p>Dosage regimen and precaution of antiviral drugs in children</p>
 </caption>
 <thead>
  <tr>
   <th align="left" colspan="1" rowspan="1" id="0-0-.">Drugs</th>
   <th align="left" colspan="1" rowspan="1" id="0-1-.">Age available</th>
   <th align="left" colspan="1" rowspan="1" id="0-2-.">Dosage regimen of COVID-19 in children</th>
   <th align="left" colspan="1" rowspan="1" id="0-3-.">Precaution/contraindication</th>
  </tr>
 </thead>
 <tbody>
  <tr>
   <td align="left">IFN-α</td>
   <td align="left">Nebulization: using with caution in neonates and infants younger than 2 months</td>
   <td align="left">
    <p>Nebulization: 200,000–400,000 IU/kg or 2–4 μg/kg in 2 mL sterile water, twice daily for 5–7 days</p>
    <p>Spray: 1–2 sprays on each nostril and 8–10 sprays on the oropharynx, once every 1–2 h, 8–10 sprays/day for 5–7 days</p>
   </td>
   <td align="left">Contraindication: CrCl &lt; 50 mL/min; histories of mental illness, severe or unstable heart disease, or aplastic anemia</td>
  </tr>
  <tr>
   <td align="left">LPVr</td>
   <td align="left">
    <p>China: OS ≥ 6 months, T ≥ 2 years</p>
    <p>USA: OS ≥ 14 days, T ≥ 6 months</p>
   </td>
   <td align="left">
    <p>Body weight (kg)</p>
    <p> 7–15: 12 mg/3 mg/kg/time, twice daily for 1–2 weeks</p>
    <p> 15–40: 10 mg/2.5 mg/kg/time, twice daily for 1–2 weeks</p>
    <p> &gt; 40: 400 mg/100 mg/time, twice daily for 1–2 weeks</p>
   </td>
   <td align="left">
    <p>Contraindication: patients with severe hepatic insufficiency</p>
    <p>Not be recommended: children with jaundice</p>
   </td>
  </tr>
  <tr>
   <td align="left">Ribavirin</td>
   <td align="left">
    <p>China: oral dosage forms ≥ 6 years</p>
    <p>USA and Europe: oral dosage forms ≥ 3 years</p>
   </td>
   <td align="left">Intravenous infusion at a dose of 10 mg/kg every time (maximum 500 mg every time), 2–3 times daily</td>
   <td align="left">
    <p>Not be recommended: CrCl &lt; 50 mL/min</p>
    <p>Should be discontinued: SCr &gt; 2 mg/dL</p>
    <p>Warning: hemolytic anemia</p>
   </td>
  </tr>
  <tr>
   <td align="left">CD</td>
   <td align="left">Using with caution</td>
   <td align="left">No recommendation</td>
   <td align="left">Acute poisoning is usually fatal with a dose of 50 mg/kg</td>
  </tr>
  <tr>
   <td align="left">Arbidol</td>
   <td align="left">≥ 2 years for influenza in Russia</td>
   <td align="left">No recommendation</td>
   <td align="left">Using with caution in patients with liver dysfunction</td>
  </tr>
 </tbody>
 <tfoot>
  <p>
   <i>IFN-α</i> interferon-α, 
   <i>LPVr</i> lopinavir/ritonavir, 
   <i>CD</i> chloroquine diphosphate, 
   <i>COVID-19</i> coronavirus disease 2019, 
   <i>CrCl</i> creatinine clearance, 
   <i>SCr</i> serum creatinine, 
   <i>OS</i> oral solutions, 
   <i>T</i> tablets 
  </p>
 </tfoot>
</table>
